Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06615193
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-19
Brief Title:
A Study of HDM2005 in Patients With RelapsedRefractory B-cell Lymphoma and Advanced Solid Tumor
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase IaIb Open-label Dose Escalation and Dose Expansion Study to Evaluate the Safety Tolerability Pharmacokinetics and Preliminary Efficacy of HDM2005 in Patients With RelapsedRefractory B-cell Lymphoma and Advanced Solid Tumor
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a first-in-human FIH study to evaluate the safety and preliminary efficacy of experimental drug HDM2005 in patients with relapsedrefractory B-cell lymphoma and advanced solid tumors
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None